Hashemi, M. Et Al. 2023. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology , vol.80 .

Hashemi, M., Ghadyani, F., Hasani, S., Olyaee, Y., Raei, B., Khodadadi, M., ... Ziyarani, M. F.(2023). Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology , vol.80.

Hashemi, Mehrdad Et Al. "Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation," Journal of Drug Delivery Science and Technology , vol.80, 2023

Hashemi, Mehrdad Et Al. "Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation." Journal of Drug Delivery Science and Technology , vol.80, 2023

Hashemi, M. Et Al. (2023) . "Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation." Journal of Drug Delivery Science and Technology , vol.80.

@article{article, author={Mehrdad Hashemi Et Al. }, title={Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation}, journal={Journal of Drug Delivery Science and Technology}, year=2023}